NSAIDs cut risk of pancreatitis post-ERCP

A one-off suppository dose of NSAIDs almost halves the risk of developing pancreatitis after endoscopic retrograde cholangiopancreatography, a randomised trial finds.

Just 9% of patients given rectal indomethacin immediately after the procedure went on to develop pancreatitis, compared with 17% of those given placebo, US researchers found.

They calculated that 13 people would need to be given the drug to prevent one episode of pancreatitis following endoscopic